Sleep and cardiovascular health are connected in population surveys and prospective studies, but the measures are not interchangeable. The evidence below separates sleep duration, coronary heart disease, myocardial infarction, stroke, hypertension, sleep apnea and cardiovascular mortality, with periods and populations stated explicitly.
Key Sleep and Heart Disease Statistics
The most broadly useful figures are:
- In prospective cohorts studied through December 2016, approximately 7 hours of sleep per day was the lowest-risk point for cardiovascular events in a pooled observational curve.
- In prospective cohorts studied through December 2016, each hour below 7 hours was associated with a 1.06 relative risk of total cardiovascular disease.
- In prospective cohorts studied through December 2016, each hour above 7 hours was associated with a 1.12 relative risk of total cardiovascular disease.
- In the United States, more than one-third of adults reported not getting the recommended amount of sleep on the CDC’s May 15, 2024 page.
- In Colorado in 2014, 28.5% of adults reported usually sleeping fewer than 7 hours in 24 hours.
- In Colorado in 2014, self-reported heart attack prevalence was 4.0% among short sleepers versus 2.9% among adults sleeping at least 7 hours.
- In Colorado in 2014, self-reported stroke prevalence was 2.3% among short sleepers versus 1.5% among adults sleeping at least 7 hours.
- Across 31 observational cohorts searched through March 2017, short sleep had a cardiovascular-mortality risk ratio of 1.19 among 816,995 participants.
- Across the same cohorts, long sleep had a cardiovascular-mortality risk ratio of 1.37.
- A 2021 American Heart Association statement estimated diagnostic-criteria obstructive sleep apnea in 34% of middle-aged men and 17% of middle-aged women.
- The 2021 AHA statement reported obstructive sleep apnea prevalence as high as 40%–80% among patients with hypertension.
- Among adults free of cardiovascular disease at baseline, difficulty initiating sleep was associated with 22% higher first-ever cardiovascular-disease incidence in evidence included through July 11, 2023.
- Among adults free of cardiovascular disease at baseline, difficulty maintaining sleep was associated with 14% higher first-ever cardiovascular-disease incidence in evidence included through July 11, 2023.
- A 2024 insomnia meta-review reported an observational summary relative risk of 1.55 for stroke across prospective cohort meta-analyses.
- In observational controlled studies searched through 2022/2023, insomnia versus no insomnia was associated with a 1.69 relative risk of myocardial infarction.
- In Colorado in 2014, short sleepers had 48.8% short-sleep prevalence among Black adults versus 26.6% among White adults.
Contents
- Key Sleep and Heart Disease Statistics
- Sleep Duration and Cardiovascular Disease Risk
- Short Sleep, Heart Disease and Stroke Data
- Long Sleep and Cardiovascular Mortality
- Sleep Apnea Statistics in Cardiovascular Disease
- Insomnia Statistics and Heart Disease Outcomes
- Population Differences and Measured Sleep–Heart Associations
Sleep Duration and Cardiovascular Disease Risk
A systematic review and dose-response meta-analysis of prospective cohorts, covering studies published through December 2016, identified approximately 7 hours per day as the lowest combined risk point for cardiovascular events. This is a pooled observational curve, not a clinical target proven by a randomized trial; sleep duration was mostly self-reported.
| Comparison with 7 hours | Total cardiovascular disease | Evidence period and population |
|---|---|---|
| Each hour shorter | RR 1.06 (95% CI 1.03–1.08) | Prospective cohorts through December 2016 |
| Each hour longer | RR 1.12 (95% CI 1.08–1.16) | Prospective cohorts through December 2016 |
| Shortest category | RR 1.14 (95% CI 1.09–1.20) | 67-article review, prospective cohorts |
| Longest category | RR 1.36 (95% CI 1.26–1.48) | 67-article review; I²=71.2% |
For coronary heart disease, each hour below 7 was associated with RR 1.07 (95% CI 1.03–1.12), while each hour above 7 was associated with RR 1.05 (95% CI 1.00–1.10). The longer-sleep coronary estimate’s confidence interval reaches 1.00, so it should not be treated as a definitive association.
For stroke, each hour below 7 was associated with RR 1.05 (95% CI 1.01–1.09), and each hour above 7 with RR 1.18 (95% CI 1.14–1.21). The extreme-category review found RR 1.09 (95% CI 0.99–1.19) for the shortest category and RR 1.45 (95% CI 1.30–1.62) for the longest category.
The dose-response evidence base contained 37 reports on total cardiovascular disease, 27 on coronary heart disease and 20 on stroke. The report counts describe the research evidence, not disease prevalence.
Source: Relationship of Sleep Duration With All-Cause Mortality and Cardiovascular Events (studies published through December 2016).
Short Sleep, Heart Disease and Stroke Data
The CDC’s “About Sleep and Your Heart Health” page, published May 15, 2024, states that more than 1 in 3 American adults report not getting the recommended amount of sleep. It also says U.S. adults sleeping fewer than 7 hours nightly are more likely to report having had a heart attack, but the page does not provide an effect size for that association.
Colorado’s 2014 age-adjusted BRFSS estimates show how short sleep and reported cardiovascular outcomes can appear together in a local sample:
| Measure, Colorado adults | Fewer than 7 hours | At least 7 hours |
|---|---|---|
| Heart attack prevalence | 4.0% | 2.9% |
| Coronary heart disease prevalence | 3.9% | 2.6% |
| Stroke prevalence | 2.3% | 1.5% |
| Obesity prevalence | 26.7% | 18.9% |
| Current smoking prevalence | 21.3% | 13.5% |
The Colorado estimates are self-reported, cross-sectional associations rather than causal effects. Obesity and smoking are related cardiovascular risk factors, not heart-disease outcomes themselves.
Short-sleep prevalence in Colorado was 29.4% among men and 27.6% among women in 2014. It ranged from 23.0% among adults aged 65 or older to 32.1% among adults aged 25–34.
The same local report found 48.8% short-sleep prevalence among Black adults compared with 26.6% among White adults. These age-adjusted local estimates should not be generalized nationally.
Source: About Sleep and Your Heart Health; Sleep and Health Among Adults (Colorado BRFSS, 2014).
Long Sleep and Cardiovascular Mortality
A systematic review searched the literature through March 2017 and combined 19 studies across 31 observational cohorts, representing 816,995 participants. Short sleep was associated with cardiovascular mortality RR 1.19 (95% CI 1.13–1.26), while long sleep was associated with RR 1.37 (95% CI 1.23–1.52).
The pooled evidence included 42,870 cardiovascular-death cases. The long-sleep estimate had high heterogeneity (I²=79.75%), and short-duration cutoffs varied between studies, so these figures are not population death counts for one country.
The earlier dose-response review also placed approximately 7 hours at the lowest-risk point for all-cause mortality and cardiovascular events among generally healthy populations. Its lowest-risk point is an observational estimate, not proof that changing sleep duration prevents cardiovascular events.
Source: Association between short and long sleep durations and cardiovascular outcomes.
Sleep Apnea Statistics in Cardiovascular Disease
The American Heart Association’s 2021 scientific statement estimates diagnostic-criteria obstructive sleep apnea in approximately 34% of middle-aged men and 17% of middle-aged women. Prevalence depends on diagnostic criteria and how populations are sampled.
Among cardiovascular-condition groups, the statement reports obstructive sleep apnea prevalence as high as 40%–80% in patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation and stroke. These are upper-range clinical-population statements, not general-population prevalence estimates.
| Population or condition | Reported sleep-apnea measure | Scope |
|---|---|---|
| Middle-aged men | Approximately 34% | Diagnostic-criteria OSA estimate |
| Middle-aged women | Approximately 17% | Diagnostic-criteria OSA estimate |
| Hypertension, heart failure, coronary disease, pulmonary hypertension, atrial fibrillation or stroke | As high as 40%–80% | Clinical populations; OSA prevalence |
| Symptomatic heart failure | 40%–60% | Sleep-disordered breathing, including obstructive and central apnea |
Because the symptomatic-heart-failure figure includes both obstructive and central sleep apnea, it is not directly interchangeable with the OSA-only estimates.
Source: Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association (published 2021).
Insomnia Statistics and Heart Disease Outcomes
A 2024 meta-review summarized observational and Mendelian-randomization evidence on insomnia and cardiovascular disease. Among adults free of cardiovascular disease at baseline, evidence included through July 11, 2023 associated non-restorative sleep with HR 1.16 (95% CI 1.07–1.24) for first-ever cardiovascular-disease incidence.
Difficulty initiating sleep was associated with HR 1.22 (95% CI 1.06–1.40), and difficulty maintaining sleep with HR 1.14 (95% CI 1.02–1.27). These are prospective observational estimates, and symptom definitions vary.
The observational summary estimates below cover prospective cohort meta-analyses:
- Insomnia and atrial fibrillation: SRR 1.30 (95% CI 1.26–1.35).
- Insomnia and coronary heart disease: SRR 1.28 (95% CI 1.10–1.50).
- Insomnia and myocardial infarction: SRR 1.42 (95% CI 1.17–1.72).
- Insomnia and stroke: SRR 1.55 (95% CI 1.39–1.72).
- Insomnia and cardiovascular disease overall: SRR 1.45 (95% CI 1.29–1.64).
A separate systematic review of studies searched through 2022/2023 found RR 1.69 (95% CI 1.41–2.02) for myocardial infarction among adults with insomnia versus no insomnia. Sleeping 5 hours or less versus 7–8 hours was associated with RR 1.56 (95% CI 1.41–1.73), while disorders of sleep initiation or maintenance were associated with RR 1.13 (95% CI 1.04–1.23).
All of these estimates are observational associations and do not establish that insomnia or short sleep directly caused the cardiovascular event.
Sources: Associations between insomnia and cardiovascular diseases (meta-review published 2024); Association between insomnia and the incidence of myocardial infarction.
Population Differences and Measured Sleep–Heart Associations
Colorado’s 2014 BRFSS data also measured conditions and behaviors that can accompany short sleep. Among short sleepers versus sufficient sleepers, physical inactivity was 21.5% versus 14.3%, depression was 27.9% versus 19.0%, and diabetes was 8.5% versus 6.1%.
These are age-adjusted, cross-sectional associations; depression and physical inactivity are not cardiovascular endpoints, while diabetes is a cardiovascular risk factor. The local design cannot determine whether sleep differences preceded or resulted from these conditions.
The 2024 insomnia meta-review also included model-dependent Mendelian-randomization estimates, largely using European genetic datasets. Per increase in insomnia liability, the reported OR was 1.14 for coronary artery disease, 1.02 for atrial fibrillation, 1.04 for heart failure, 1.16 for hypertension and 1.09 for any ischemic stroke.
The genetic estimates had substantial heterogeneity: I² was 97% for coronary artery disease, 94% for atrial fibrillation, 97% for heart failure and 60% for any ischemic stroke. Hypertension is a cardiovascular risk factor rather than an outcome identical to heart disease, and genetic-instrument results depend on the model and assumptions used.
Source: Associations between insomnia and cardiovascular diseases; local prevalence and risk-factor comparisons: Sleep and Health Among Adults (Colorado BRFSS, 2014).